Blackstone Inc Rezolute, Inc. Transaction History
Blackstone Inc
- $24.2 Billion
- Q1 2024
A detailed history of Blackstone Inc transactions in Rezolute, Inc. stock. As of the latest transaction made, Blackstone Inc holds 1,537,684 shares of RZLT stock, worth $6.61 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,537,684
Previous 1,537,684
-0.0%
Holding current value
$6.61 Million
Previous $1.52 Million
157.62%
% of portfolio
0.02%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding RZLT
# of Institutions
33Shares Held
26.8MCall Options Held
0Put Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA10.2MShares$43.7 Million0.06% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.02MShares$13 Million0.5% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$12 Million0.95% of portfolio
-
Affinity Asset Advisors, LLC New York, NY1.6MShares$6.88 Million0.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.55MShares$6.68 Million0.0% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $167M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...